• Cipmolnu 200 Capsule is the first oral antiviral medication that helps treat mild to moderate COVID-19 in adults
• It prevents the virus from multiplying, thereby reducing viral load and disease severity
• The drug received emergency use approval from Indian drug regulatory authorities on December 28, 2021
• Cipmolnu 200 Capsule is only indicated in patients with mild to moderate COVID-19 symptoms and who have a high risk of developing severe symptoms
• The risk factors include obesity, older age (>60 years), diabetes mellitus, and heart diseases
• It is not indicated in patients who require immediate hospitalization due to COVID-19
• This drug has also been approved by the U.S
• Food and Drug Administration (FDA) and the UK regulatory agency for emergency use.Cipmolnu 200 Capsule should be taken orally for no longer than 5 consecutive days
• It is important to complete the entire 5 days of treatment, therefore do not stop taking it even if you feel better
• The medicine may cause dizziness, headache, diarrhea, and nausea in some patients
• If one experiences any such side effects, discuss them with the doctor
• They may help with the treatment or suggest ways to prevent them.
• Before taking Cipmolnu 200 Capsule, let the doctor know if you have any pre-existing medical conditions
• To make sure it is safe for you, inform your doctor about all the other medications you are taking
• The use of Cipmolnu 200 Capsule is not recommended in pregnant women
• Pregnant and breastfeeding women should consult with their doctors before taking this medicine.

Uses of Cipmolnu 200 Capsule

• In Treatment of Mild to moderate Coronavirus disease (COVID-19) Cipmolnu 200 Capsule helps manage mild to moderate Covid-19 symptoms in those individuals who are at a high risk of developing severe Covid-19 disease and do not need oxygen administration
• This medicine may help you recover from the infection if diagnosed early before hospitalization
• If you think you have come in contact with a person who has been infected with Covid-19, or if you feel any of these symptoms, consult your doctor immediately.

Missed Doses

If you miss a dose of Cipmolnu 200 Capsule, please consult your doctor.

Frequestly asked Questions

Can Cipmolnu 200 Capsule be given to children?

No, Cipmolnu 200 Capsule is not approved for use in children or patients below the age of 18 years as it may interfere with the growth of bones and cartilage.

What is the advantage of using Cipmolnu 200 Capsule?

Cipmolnu 200 Capsule has better patient compliance than some other treatment options available against COVID-19. Unlike other medicines that may need a skilled healthcare professional (a doctor or a nurse) to administer, Cipmolnu 200 Capsule is an oral medicine that can be consumed by mouth in the dosage and schedule prescribed by the doctor.

Are there any serious risks of taking Cipmolnu 200 Capsule?

Yes, there are some serious risks involved with using Cipmolnu 200 Capsule, including its potential to cause birth defects in pregnant women and serious damage to the growth of bones and cartilage (which may cause serious muscle damage). Therefore, Cipmolnu 200 Capsule should be used only if prescribed by a doctor and not used for self-medication.

Is taking Cipmolnu 200 Capsule better than getting vaccinated?

No. There is no comparison between the two, and Cipmolnu 200 Capsule is not a substitute for getting vaccinated. Vaccination is for prevention, while Cipmolnu 200 Capsule is used to treat an existing COVID-19 infection, provided the infection is diagnosed at an early stage.

Who is at a high risk of developing severe COVID-19?

People who are at a high risk of developing severe COVID-19 include those aged above 60 years, who are obese, have comorbid conditions including high blood pressure, diabetes, asthma, other medical conditions related to the lungs, kidneys (like dialysis patients), liver, or those who have a weak immunity (like cancer patients).

Who should not take Cipmolnu 200 Capsule?

Cipmolnu 200 Capsule should not be taken to prevent COVID-19 or treat patients hospitalized due to COVID-19. According to the ongoing clinical trials, patients hospitalized with severe COVID-19 infection have not benefited from taking Cipmolnu 200 Capsule.

Common and Known Side effects of Cipmolnu 200 Capsule

• Nausea
• Dizziness
• Diarrhea